Clinical trial
Epothilone B in Treating Patients With CNS Metastases From Breast Cancer
NCT00450866 · David Peereboom, MD, Other · Completed
Key facts
| NCT number | NCT00450866 |
|---|---|
| Title | Epothilone B in Treating Patients With CNS Metastases From Breast Cancer |
| Official title | Phase II Trial of Patupilone in Patients With Brain Metastases From Breast Cancer |
| Lead sponsor | David Peereboom, MD, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Metastatic Cancer |
| Intervention type | Biological |
| Interventions | epothilone B |
| Enrollment | 55 |
| Start date | Jan 1, 2007 |
| Primary completion | Jun 1, 2011 |
| Completion | May 1, 2012 |
| First posted | Mar 22, 2007 |
| Last update posted | Feb 28, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: